Guggenheim initiated coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research note released on Thursday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $90.00 target price on the medical research company’s stock. EXAS has been the subject of several other reports. Wolfe Research began coverage on shares of […]
Exact Sciences (NASDAQ:EXAS) Receives Outperform Rating from William Blair theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month price […]
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price decreased by Piper Sandler from $90.00 to $80.00 in a research note issued to investors on Monday, Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. A number of other research firms have also weighed in on EXAS. The […]
Brokerages Set Exact Sciences Co (NASDAQ:EXAS) Target Price at $96 18 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.